Oneness Biotech Co., Ltd.(TW:4743)
NT$46.25-0.85 (-1.80%)
TW:4743
Oneness Biotech Co., Ltd. financials statements
NT$46.25
At close:-0.85 (-1.80%)
Oneness Biotech Co., Ltd. (4743) Income Statement
Oneness Biotech Co., Ltd. Income Statement
Last quarter (Q2 2026), Oneness Biotech Co., Ltd.'s total revenue was NT$35.35M, an increase of 32.64% from the same quarter last year. In Q2, Oneness Biotech Co., Ltd.'s net income was NT$248.54M. See Oneness Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 129.12M | NT$ 117.93M | NT$ 86.78M | NT$ 1.07B | NT$ 65.77M | |
| NT$ 35.95M | NT$ 63.03M | NT$ 32.56M | NT$ 844.39M | NT$ 45.04M | |
| NT$ 838.96M | NT$ 1.15B | NT$ 1.13B | NT$ 1.09B | NT$ 923.18M | |
| Depreciation and Amortization | NT$ 333.91M | NT$ 454.41M | NT$ 448.99M | NT$ 494.64M | NT$ 197.34M |
| NT$ -469.09M | NT$ -685.71M | NT$ -647.63M | NT$ 253.19M | NT$ -193.72M | |
| NT$ -803.01M | NT$ -1.09B | NT$ -1.10B | NT$ 456.22M | NT$ -391.06M | |
| NT$ -253.05M | NT$ -64.31M | NT$ 278.12M | NT$ 695.35M | NT$ 482.18M | |
| NT$ -1.06B | NT$ -1.15B | NT$ -1.32B | NT$ 451.63M | NT$ -395.96M | |
| NT$ -1.04B | NT$ -1.17B | NT$ -1.31B | NT$ 359.98M | NT$ -412.82M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.18 | NT$ -2.44 | NT$ -2.77 | NT$ 0.82 | NT$ -0.95 |
| Diluted EPS | NT$ -2.18 | NT$ -2.44 | NT$ -2.77 | NT$ 0.80 | NT$ -0.95 |
| Weighted Average Shares Outstanding | 479.25M | 477.52M | 473.96M | 441.49M | 433.70M |
| Weighted Average Shares Outstanding (Diluted) | 479.25M | 477.52M | 473.96M | 447.94M | 433.70M |
Currency in TWD

